These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32252121)

  • 21. Associations between the probabilities of frequency-specific hearing loss and unaided APHAB scores.
    Löhler J; Wollenberg B; Schlattmann P; Hoang N; Schönweiler R
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1345-1349. PubMed ID: 27858146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
    Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
    Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
    Schmidt CM; Bartholomäus E; Deuster D; Heinecke A; Dinnesen AG
    HNO; 2007 Apr; 55(4):299-306. PubMed ID: 16437215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of affordable instruments for hearing screening in adults and the elderly.
    Balen SA; Vital BSB; Pereira RN; Lima TF; Barros DMDS; Lopez EA; Diniz Junior J; Valentim RAM; Ferrari DV
    Codas; 2021; 33(5):e20200100. PubMed ID: 34231667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-Reported Hearing Loss and Pure Tone Audiometry for Screening in Primary Health Care Clinics.
    Louw C; Swanepoel W; Eikelboom RH
    J Prim Care Community Health; 2018; 9():2150132718803156. PubMed ID: 30278815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed-Level Frequency Threshold Testing for Ototoxicity Monitoring.
    Rieke CC; Clavier OH; Allen LV; Anderson AP; Brooks CA; Fellows AM; Brungart DS; Buckey JC
    Ear Hear; 2017; 38(6):e369-e375. PubMed ID: 28362673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digit Triplet Test Hearing Screening With Broadband and Low-Pass Filtered Noise in a Middle-Aged Population.
    Vercammen C; Goossens T; Wouters J; van Wieringen A
    Ear Hear; 2018; 39(4):825-828. PubMed ID: 29189521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of self-reported hearing and pure tone threshold average in the Iowa Farm Family Health and Hazard Survey.
    Choi SW; Peek-Asa C; Zwerling C; Sprince NL; Rautiainen RH; Whitten PS; Flamme GA
    J Agromedicine; 2005; 10(3):31-9. PubMed ID: 16537314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Hearing Loss Associated with Poorer Health in Older Adults Who Might Benefit from Hearing Screening?
    Mick P; Pichora-Fuller MK
    Ear Hear; 2016; 37(3):e194-201. PubMed ID: 26825862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of Mobile-Based Audiometry in the Evaluation of Hearing Loss in Quiet and Noisy Environments.
    Saliba J; Al-Reefi M; Carriere JS; Verma N; Provencal C; Rappaport JM
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):706-711. PubMed ID: 28025906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the use of a questionnaire to detect hearing loss in Kenyan pre-school children.
    Newton VE; Macharia I; Mugwe P; Ototo B; Kan SW
    Int J Pediatr Otorhinolaryngol; 2001 Mar; 57(3):229-34. PubMed ID: 11223455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of pure-tone hearing screening at well-child visits.
    Halloran DR; Hardin JM; Wall TC
    Arch Pediatr Adolesc Med; 2009 Feb; 163(2):158-63. PubMed ID: 19188648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a computer-based automated pure tone hearing screening device: a preliminary clinical trial.
    Gan KB; Azeez D; Umat C; Ali MA; Wahab NA; Mukari SZ
    Biomed Tech (Berl); 2012 Oct; 57(5):323-32. PubMed ID: 25854660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Preliminary Study Investigating the Association Between Hearing Acuity and a Screening Cognitive Tool.
    Mukari SZS; Ishak WS; Maamor N; Wan Hashim WF
    Ann Otol Rhinol Laryngol; 2017 Oct; 126(10):697-705. PubMed ID: 28845678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tablet-based Screening for Hearing Loss: Feasibility of Testing in Nonspecialty Locations.
    Kelly EA; Stadler ME; Nelson S; Runge CL; Friedland DR
    Otol Neurotol; 2018 Apr; 39(4):410-416. PubMed ID: 29494473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for handicapping hearing loss in the elderly.
    Gates GA; Murphy M; Rees TS; Fraher A
    J Fam Pract; 2003 Jan; 52(1):56-62. PubMed ID: 12540314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validating self-reporting of hearing-related symptoms against pure-tone audiometry, otoacoustic emission, and speech audiometry.
    Fredriksson S; Hammar O; Magnusson L; Kähäri K; Persson Waye K
    Int J Audiol; 2016 Aug; 55(8):454-62. PubMed ID: 27195802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telephone screening tests for functionally impaired hearing: current use in seven countries and development of a US version.
    Watson CS; Kidd GR; Miller JD; Smits C; Humes LE
    J Am Acad Audiol; 2012; 23(10):757-67. PubMed ID: 23169193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.